Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine monotherapy vs. patients without rheumatic conditions: a retrospective, propensity-matched cohort study

{ 'indexed': {'date-parts': [[2022, 9, 11]], 'date-time': '2022-09-11T14:13:58Z', 'timestamp': 1662905638811}, 'reference-count': 18, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 9, 1]], 'date-time': '2022-09-01T00:00:00Z', 'timestamp': 1661990400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.com.au', 'clinicalkey.es', 'amjmedsci.org', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 9]]}, 'DOI': '10.1016/j.amjms.2022.08.006', 'type': 'journal-article', 'created': {'date-parts': [[2022, 9, 11]], 'date-time': '2022-09-11T13:32:07Z', 'timestamp': 1662903127000}, 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine ' 'monotherapy vs. patients without rheumatic conditions: a retrospective, propensity-matched ' 'cohort study', 'prefix': '10.1016', 'author': [ {'given': 'Chris A.', 'family': 'Gentry', 'sequence': 'first', 'affiliation': []}, {'given': 'Sharanjeet K.', 'family': 'Thind', 'sequence': 'additional', 'affiliation': []}, { 'suffix': 'II', 'given': 'Riley J.', 'family': 'Williams', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sage C.', 'family': 'Hendrickson', 'sequence': 'additional', 'affiliation': []}, {'given': 'George', 'family': 'Kurdgelashvili', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mary Beth', 'family': 'Humphrey', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.amjms.2022.08.006_bib0001', 'article-title': 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ' 'coronavirus disease-2019 (COVID-19): The epidemic and the challenges', 'volume': '55', 'author': 'Lai', 'year': '2020', 'journal-title': 'Int J Antimicrobe Agents'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0002', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0003', 'doi-asserted-by': 'crossref', 'first-page': '732', 'DOI': '10.1093/cid/ciaa237', 'article-title': 'In vitro antiviral activity and projection of optimized dosing design ' 'of hydroxychloroquine for the treatment of severe acute respiratory ' 'syndrome Coronavirus 2 (SARS-CoV-2)', 'volume': '28', 'author': 'Yao', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0004', 'doi-asserted-by': 'crossref', 'first-page': '30', 'DOI': '10.1093/jac/dkaa403', 'article-title': 'Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a ' 'systematic review and meta-analysis', 'volume': '76', 'author': 'Kashour', 'year': '2021', 'journal-title': 'J Antimicrob Chemother'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '19', 'DOI': '10.1016/j.cmi.2020.08.022', 'article-title': 'Effect of hydroxychloroquine with or without azithromycin on the ' 'mortality of coronavirus disease 2019 (COVID-19) patients: a systematic ' 'review and meta-analysis', 'volume': '27', 'author': 'Fiolet', 'year': '2021', 'journal-title': 'Clin Microbiol Infect'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0006', 'article-title': 'Serious cardiovascular adverse events associated with ' 'hydroxychloroquine/chloroquine alone or with azithromycin in patients ' 'with COVID-19: a pharmacovigilance analysis of the FDA adverse event ' 'reporting system (FAERS)', 'author': 'Zhao', 'year': '2022', 'journal-title': 'Advance online publication'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '517', 'DOI': '10.1056/NEJMoa2016638', 'article-title': 'A randomized trial of hydroxychloroquine as postexposure prophylaxis ' 'for Covid-19', 'volume': '383', 'author': 'Boulware', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0008', 'doi-asserted-by': 'crossref', 'first-page': '344', 'DOI': '10.7326/M20-6519', 'article-title': 'Hydroxychloroquine as postexposure prophylaxis to prevent severe acute ' 'respiratory syndrome coronavirus 2 infection', 'volume': '174', 'author': 'Barnabas', 'year': '2021', 'journal-title': 'Ann Intern Med'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0009', 'doi-asserted-by': 'crossref', 'first-page': '417', 'DOI': '10.1056/NEJMoa2021801', 'article-title': 'A cluster-randomized trial of hydroxychloroquine for prevention of ' 'Covid-19', 'volume': '384', 'author': 'Mitja', 'year': '2021', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '195', 'DOI': '10.1001/jamainternmed.2020.6319', 'article-title': 'Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure ' 'SARS-CoV-2 prophylaxis among health care workers', 'volume': '181', 'author': 'Abella', 'year': '2021', 'journal-title': 'JAMA Intern Med'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0011', 'doi-asserted-by': 'crossref', 'first-page': 'e835', 'DOI': '10.1093/cid/ciaa1571', 'article-title': 'Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in ' 'healthcare workers: a randomized trial', 'volume': '72', 'author': 'Rajasingham', 'year': '2021', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0012', 'doi-asserted-by': 'crossref', 'first-page': '561', 'DOI': '10.1007/s40121-020-00325-2', 'article-title': 'The pharmacokinetic and pharmacodynamic properties of ' 'hydroxychloroquine and dose selection for COVID-19: putting the cart ' 'before the horse', 'volume': '9', 'author': 'Morrisette', 'year': '2020', 'journal-title': 'Infect Dis Ther'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0013', 'doi-asserted-by': 'crossref', 'first-page': 'e689', 'DOI': '10.1016/S2665-9913(20)30305-2', 'article-title': 'Long-term hydroxychloroquine use in patients with rheumatic conditions ' 'and development of SARS-CoV-2 infection: a retrospective cohort study', 'volume': '2', 'author': 'Gentry', 'year': '2020', 'journal-title': 'Lancet Rheumatol'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '2411', 'DOI': '10.1056/NEJMoa2012410', 'article-title': 'Observational Study of Hydroxychloroquine in Hospitalized Patients with ' 'Covid-19', 'volume': '382', 'author': 'Geleris', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0015', 'doi-asserted-by': 'crossref', 'first-page': 'm1844', 'DOI': '10.1136/bmj.m1844', 'article-title': 'Clinical efficacy of hydroxychloroquine in patients with covid-19 ' 'pneumonia who require oxygen: observational comparative study using ' 'routine care data', 'volume': '369', 'author': 'Mahevas', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0016', 'doi-asserted-by': 'crossref', 'first-page': '2493', 'DOI': '10.1001/jama.2020.8630', 'article-title': 'Association of Treatment With Hydroxychloroquine or Azithromycin With ' 'In-Hospital Mortality in Patients With COVID-19 in New York State', 'volume': '323', 'author': 'Rosenberg', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.amjms.2022.08.006_bib0017', 'doi-asserted-by': 'crossref', 'first-page': '72', 'DOI': '10.5582/bst.2020.01047', 'article-title': 'Breakthrough: chloroquine phosphate has shown apparent efficacy in ' 'treatment of COVID-19 associated pneumonia in clinical studies', 'volume': '14', 'author': 'Goa', 'year': '2020', 'journal-title': 'Biosci Trends'}, { 'issue': '1', 'key': '10.1016/j.amjms.2022.08.006_bib0018', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'volume': '56', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents. Int J Antimicrob Agents'}], 'container-title': 'The American Journal of the Medical Sciences', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0002962922003482?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0002962922003482?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 9, 11]], 'date-time': '2022-09-11T13:32:21Z', 'timestamp': 1662903141000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0002962922003482'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 9]]}, 'references-count': 18, 'alternative-id': ['S0002962922003482'], 'URL': 'http://dx.doi.org/10.1016/j.amjms.2022.08.006', 'relation': {}, 'ISSN': ['0002-9629'], 'subject': ['General Medicine'], 'container-title-short': 'The American Journal of the Medical Sciences', 'published': {'date-parts': [[2022, 9]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Development of SARS-CoV-2 infection in patients with rheumatic conditions on ' 'hydroxychloroquine monotherapy vs. patients without rheumatic conditions: a ' 'retrospective, propensity-matched cohort study', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'The American Journal of the Medical Sciences', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.amjms.2022.08.006', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2022 Published by Elsevier Inc. on behalf of Southern Society for Clinical ' 'Investigation.', 'name': 'copyright', 'label': 'Copyright'}]}